Findings in the current study that high tumor expression of PRCP correlates with worse outcomes in TNBC patients suggest its ability to promote RTK signaling may lead to more aggressive tumors, as well as further indicate the prognostic potential of PRCP is not limited to ER+ cancers. This evidence concerns the gene PRCP and cancer.